Page 136 - Essential Haematology
P. 136

122  /  Chapter 8  White cells: Granulocytes and monocytes


                                                              multisystem disease who do not respond to

                         Table 8.7   Classifi cation of the histiocytic and
                     dendritic cell disorders.                chemotherapy.
                           Benign                                 Haemophagocytic  l ymphohistiocytosis
                           Dendritic cell - related           ( h aemophagocytic  s yndrome)
                         Langerhans ’  cell histiocytosis
                                                               This is a rare, recessively inherited or more fre-

                         Solitary dendritic cell histiocytoma
                                                              quently acquired disease, usually precipitated by a
                           Histiocyte - related               viral (especially Epstein – Barr or herpes viruses),
                         Haemophagocytic lymphohistiocytosis     bacterial or fungal infection or occuring in associa-
                             primary (familial)               tion with tumours. Often the patient is immuno-
                             secondary  –  infection, drug, tumour     compromised. Patients present with fever and
                         Sinus histiocytosis with massive     pancytopenia, often with splenomegaly and liver
                      lymphadenopathy (Rosai – Dorfman syndrome)

                                                              dysfunction. There are increased numbers of histio-
                           Malignant                          cytes in the bone marrow which ingest red cells,
                         Dendritic and histiocytic sarcomas (localized or   white cells and platelets (Fig.  8.12 ). Clinical features
                      disseminated)                           are fever, pancytopenia and multiorgan dysfunction

                         AML, monocytic and myelomonocytic  (see p.   often with lymphadenopathy, hepatic and splenic

                      179)                                    enlargement, coagulopathy and CNS signs.
                         Chronic myelomonocytic leukaemia  (see p. 221)           Treatment is of the underlying infection, if known,


                                                              with support care. T - cell activation is implicated in
                           AML, acute myeloid leukaemia.       the aetiology. Chemotherapy with etoposide, corti-
                                                              costeroids, ciclosporin or rituximab (anti - CD20)
                                                              may be tried. The condition is often fatal.

                       2      A lymphocyte - derived subset. The primary role

                      of dendritic cells is antigen presentation to T and
                                                                  Sinus  h istiocytosis with  m assive
                      B lymphocytes    (see p. 133)   .
                                                                l ymphadenopathy
                                                               Th is is also known as the Rosai – Dorfman syn-
                        Langerhans ’   c ell  h istiocytes

                                                              drome. There is painless, chronic cervical lymphad-
                     Langerhans ’  cell histiocytosis (LCH) includes dis-  enopathy. There may be fever and weight loss. Th e

                    eases previously called  histiocytosis X,   Letterer – Siwe   histology is typical and the condition subsides over
                    disease    Hand – Sch ü ller – Christian  disease  and  eosi-  months or years.
                        ,
                    nophilic granuloma . The disease may be single organ

                    or multisystem. There is a clonal proliferation of       Lysosomal  s torage  d iseases

                    CD1a - positive cells. The multisystem disease aff ects


                    children in the first 3 years of life with hepato-   Gaucher ’ s, Tay – Sachs  and  Niemann – Pick  diseases

                    splenomegaly, lymphadenopathy and eczematous   result from hereditary deficiency of enzymes
                    skin symptoms. Localized lesions may occur espe-  required for glycolipid breakdown.
                    cially in the skull, ribs and long bones, the posterior
                    pituitary causing diabetes insipidus, the central
                                                                  Gaucher ’ s  d isease
                    nervous system, gastrointestinal tract and lungs.
                                                                    ’
                    The lesions include Langerhans ’  cells (characterized     Gaucher  s disease is an uncommon autosomal reces-

                    by the presence of tennis racquet - shaped Birbeck   sive disorder characterized by an accumulation of
                    granules in electron - microscopy sections), eosi-  glucosylceramide in the lysosomes of reticuloen-

                    nophils, lymphocytes, neutrophils and macro-  dothelial cells as a result of deficiency of glucocere-


                    phages. The prognosis is better for localized disease   brosidase (Fig.  8.13 . Three types occur: a chronic
                    but there is a 66% mortality in young children with   adult type (type I); an acute infantile neuronopathic
   131   132   133   134   135   136   137   138   139   140   141